Synairgen's inhalable drug fails study in hospitalized COVID-19 patients
SNG001 is also being tested in a medical trial by the US National Institute of Health.
Vials of investigational coronavirus disease (COVID-19) treatment drug are capped at a facility.(photo credit: GILEAD SCIENCES INC/HANDOUT VIA REUTERS)ByREUTERSUpdated:
